Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × urelumab × Clear all

NCT02652455 2025-08-19

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Phase EARLY_PHASE1 Completed

Melanoma, Skin Neoplasms